期刊文献+

Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population 被引量:7

Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population
原文传递
导出
摘要 Background:Idiopathic membranous nephropathy (IMN) is an autoimmune disease and the leading cause of adult nephritic syndrome.HLA-DQA1 had been identified to be associated with IMN in Europeans and the result was replicated in Chinese Han population.In this study,six single nucleotide polymorphisms (SNPs) in the promoter ofHLA-DQA I and other two SNPs with IgA nephropathy were included for the association analysis.Methods:The SNPs were genotyped in 509 patients and 601 controls by the MassArray iPLEX.The quantification ofanti-phospholipase A2 receptor (PLA2R) antibodies in sera of IMN patients was performed by anti-PLA2R ELISA (lgG) kit.Results:After analysis,four SNPs were significantly associated with IMN,with rs2187668 and rs28383345 as the top two signals (P =8.42×10-4 and 2.48× 10-5,respectively).Even under dominant model,the two SNPs were still significantly associated with IMN (P =3.50×10-3 for rs28383345 and P =6.55×10-5 for rs2187668).After conditional study with rs2187668,rs28383345 was the only variant significantly correlated with IMN after Bonferroni correction (P =0.016).The minor alleles of the two SNPs were also mutually exclusive in our cohort.This indicated that the two SNPs were independently associated with IMN in Chinese Han population.Levels of anti-PLA2R autoantibodies were correlated with the genotypes of the two SNPs,but not significantly (P〉0.05).Conclusions:Our results revealed that a novel independent variant in the promoter of HLA-DQA I was associated with I MN in Chinese Han population.The locus possessed regulatory role according to the data of RegulomeDB.The exact role of the SNPs on the expression of HLAoDQA1 needs further investigation. Background:Idiopathic membranous nephropathy (IMN) is an autoimmune disease and the leading cause of adult nephritic syndrome.HLA-DQA1 had been identified to be associated with IMN in Europeans and the result was replicated in Chinese Han population.In this study,six single nucleotide polymorphisms (SNPs) in the promoter ofHLA-DQA I and other two SNPs with IgA nephropathy were included for the association analysis.Methods:The SNPs were genotyped in 509 patients and 601 controls by the MassArray iPLEX.The quantification ofanti-phospholipase A2 receptor (PLA2R) antibodies in sera of IMN patients was performed by anti-PLA2R ELISA (lgG) kit.Results:After analysis,four SNPs were significantly associated with IMN,with rs2187668 and rs28383345 as the top two signals (P =8.42×10-4 and 2.48× 10-5,respectively).Even under dominant model,the two SNPs were still significantly associated with IMN (P =3.50×10-3 for rs28383345 and P =6.55×10-5 for rs2187668).After conditional study with rs2187668,rs28383345 was the only variant significantly correlated with IMN after Bonferroni correction (P =0.016).The minor alleles of the two SNPs were also mutually exclusive in our cohort.This indicated that the two SNPs were independently associated with IMN in Chinese Han population.Levels of anti-PLA2R autoantibodies were correlated with the genotypes of the two SNPs,but not significantly (P〉0.05).Conclusions:Our results revealed that a novel independent variant in the promoter of HLA-DQA I was associated with I MN in Chinese Han population.The locus possessed regulatory role according to the data of RegulomeDB.The exact role of the SNPs on the expression of HLAoDQA1 needs further investigation.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第14期1677-1682,共6页 中华医学杂志(英文版)
关键词 Autoimmune Disease HLA-DQA1 Idiopathic Membranous Nephropathy PROMOTER CHINESE Autoimmune Disease HLA-DQA1 Idiopathic Membranous Nephropathy Promoter Chinese
  • 相关文献

参考文献2

二级参考文献6

  • 1Bomback AS, Derebail VK, McGregor JG, Kshirsagar AV, Falk RJ, Nachman PH. Rituximab therapy for membranous nephropathy: A systematic review. Clin J Am Soc Nephrol 2009;4:734-44. doi: 10.2215CJN.05231008.
  • 2Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, et al. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 2012;23:1416-25. doi: 10.1681ASN.2012020181.
  • 3Bredemeier M, de Oliveira FK, Rocha CM. Low- versus high-dose rituximab for rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2014;66:228-35. doi: 10.1002acr.22116abstract.
  • 4Kurosu N, Sugiura H, Iwasaki C, Asamiya Y, Kojima C, Moriyama T, et al. Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med 2009;48:1901-4. doi: 10.2169internalmedicine.48.2435.
  • 5Cho JH, Lee JH, Park GY, Lira JH, Kim JS, Kang YJ, et al. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient. Ren Fail 2014;36:623-6. doi: 10.31090886022X.2014.882238.
  • 6Xiao-Pei Wang,Zhano-Xue Hu,Dong-Yang Guo,Ye Tao.Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report[J].Chinese Medical Journal,2016(7):871-873. 被引量:8

共引文献14

同被引文献38

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部